<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03640507</url>
  </required_header>
  <id_info>
    <org_study_id>AAAR4891</org_study_id>
    <nct_id>NCT03640507</nct_id>
  </id_info>
  <brief_title>Vaginal Preparation With Chlorhexidine-alcohol vs. Povidine-iodine vs. Saline</brief_title>
  <official_title>The Effect of Vaginal Preparation With Chlorhexidine-alcohol vs. Povidine-iodine vs. Saline on Vaginal Bacteria Colony Counts in Pregnant Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to see whether chlorhexidine is superior to povidine-iodine
      vaginal antisepsis at reducing bacteria colony counts in pregnant women by comparing three
      groups: vaginal washing with chlorhexidine-alcohol, vaginal washing with povidine-iodine, and
      vaginal washing with saline alone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective trial of vaginal preparation (or vaginal cleansing/washing) on late
      preterm and term pregnancies admitted to Labor &amp; Delivery unit for cesarean delivery with
      three arms. Randomization allocation would be performed in 1:1:1 fashion for vaginal
      preparation with chlorhexidine-alcohol, povidine-iodine, and saline washes. A saline wash
      group is included to determine if the act of cleansing the vagina with a sponge alone reduces
      bacterial colony counts.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Actual">June 14, 2019</completion_date>
  <primary_completion_date type="Actual">May 8, 2019</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-intervention Aerobic Bacterial Colony Counts</measure>
    <time_frame>From intervention to 7 days post</time_frame>
    <description>Vaginal cultures are collected after the vaginal preparation intervention. These undergo serial dilutions and are incubated on Tryptic Soy Agar for seven days. Bacteria colony counts were determined by blinded investigators on day 7.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-intervention Anaerobic Bacterial Colony Counts</measure>
    <time_frame>From intervention to 7 days post</time_frame>
    <description>Vaginal cultures are collected after the vaginal preparation intervention. These undergo serial dilutions and are incubated on Tryptic Soy Agar for seven days. Bacteria colony counts were determined by blinded investigators on day 7.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Baseline Aerobic Bacterial Colony Counts</measure>
    <time_frame>From intervention to 7 days post</time_frame>
    <description>Vaginal cultures are collected immediately prior to the vaginal preparation intervention. These undergo serial dilutions and are incubated on Tryptic Soy Agar for seven days. Bacteria colony counts were determined by blinded investigators on day 7.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline Anaerobic Bacterial Colony Counts</measure>
    <time_frame>From intervention to 7 days post</time_frame>
    <description>Vaginal cultures are collected immediately prior to the vaginal preparation intervention. These undergo serial dilutions and are incubated on Tryptic Soy Agar for seven days. Bacteria colony counts were determined by blinded investigators on day 7.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Number of Participants Diagnosed With Postpartum Infections.</measure>
    <time_frame>Up to six weeks postpartum</time_frame>
    <description>Chart review to assess any maternal infections diagnosed during postpartum hospitalization or at the time of the postpartum visit.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Cesarean Section; Infection</condition>
  <condition>Surgical Site Infection</condition>
  <arm_group>
    <arm_group_label>Chlorhexidine-alcohol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will receive vaginal preparation with chlorhexidine-alcohol.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Povidine-iodine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will receive vaginal preparation with povidine-iodine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects will receive vaginal preparation with sterile saline.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chlorhexidine-alcohol</intervention_name>
    <description>Intervention is a 30-second vaginal preparation or topical wash with three chlorhexidine-alcohol 0.5% solution-soaked sponge sticks.</description>
    <arm_group_label>Chlorhexidine-alcohol</arm_group_label>
    <other_name>Chlorohexidine Gluconate (CHG)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Povidine-iodine</intervention_name>
    <description>Intervention is a 30-second vaginal preparation or topical wash with three povidine-iodine 10% solution-soaked sponge sticks.</description>
    <arm_group_label>Povidine-iodine</arm_group_label>
    <other_name>Betadine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sterile saline</intervention_name>
    <description>Intervention is a 30-second vaginal preparation or topical wash with three sterile saline-soaked sponge sticks.</description>
    <arm_group_label>Saline</arm_group_label>
    <other_name>Sodium chloride 0.9%</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Intervention Group (vaginal preparation)

        Inclusion Criteria:

          -  Pregnant women admitted for cesarean delivery

          -  Gestational age greater than or equal to 34 weeks

        Exclusion Criteria:

          -  Rupture of membranes or active labor

          -  Chorioamnionitis (prior to enrollment)

          -  Recent (within 4 weeks) antibiotic exposure

          -  Maternal HIV infection or immunocompromised state

          -  Known allergy to shellfish, iodine, or chlorhexidine
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yiping Han, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University Department of Microbiology and Immunology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New York Presbyterian Hospital at Columbia University and Children's Hospital of New York</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>August 17, 2018</study_first_submitted>
  <study_first_submitted_qc>August 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 21, 2018</study_first_posted>
  <results_first_submitted>May 14, 2020</results_first_submitted>
  <results_first_submitted_qc>May 14, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">June 1, 2020</results_first_posted>
  <last_update_submitted>May 29, 2020</last_update_submitted>
  <last_update_submitted_qc>May 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Yiping Weng Han</investigator_full_name>
    <investigator_title>Professor of Microbial Sciences</investigator_title>
  </responsible_party>
  <keyword>vaginal preparation</keyword>
  <keyword>antisepsis</keyword>
  <keyword>C-section</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Surgical Wound Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 10, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/07/NCT03640507/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants will be recruited in-person only by study investigators/trained research personnel after admission to labor and delivery prior to administration of sedatives, anesthetics, or other mental-altering medications (note: some patients included in study will be in labor and may have already received regional anesthesia).</recruitment_details>
      <pre_assignment_details>Participants need to be confirmed to be undergoing a Cesarean procedure.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Chlorhexidine-alcohol</title>
          <description>Subjects will receive vaginal preparation with chlorhexidine-alcohol.
Chlorhexidine-alcohol: Intervention is a 30-second vaginal preparation or topical wash with three chlorhexidine-alcohol 0.5% solution-soaked sponge sticks.</description>
        </group>
        <group group_id="P2">
          <title>Povidine-iodine</title>
          <description>Subjects will receive vaginal preparation with povidine-iodine.
Povidine-iodine: Intervention is a 30-second vaginal preparation or topical wash with three povidine-iodine 10% solution-soaked sponge sticks.</description>
        </group>
        <group group_id="P3">
          <title>Saline</title>
          <description>Subjects will receive vaginal preparation with sterile saline.
Sterile saline: Intervention is a 30-second vaginal preparation or topical wash with three sterile saline-soaked sponge sticks.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Chlorhexidine-alcohol</title>
          <description>Subjects will receive vaginal preparation with chlorhexidine-alcohol.
Chlorhexidine-alcohol: Intervention is a 30-second vaginal preparation or topical wash with three chlorhexidine-alcohol 0.5% solution-soaked sponge sticks.</description>
        </group>
        <group group_id="B2">
          <title>Povidine-iodine</title>
          <description>Subjects will receive vaginal preparation with povidine-iodine.
Povidine-iodine: Intervention is a 30-second vaginal preparation or topical wash with three povidine-iodine 10% solution-soaked sponge sticks.</description>
        </group>
        <group group_id="B3">
          <title>Saline</title>
          <description>Subjects will receive vaginal preparation with sterile saline.
Sterile saline: Intervention is a 30-second vaginal preparation or topical wash with three sterile saline-soaked sponge sticks.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="9"/>
            <count group_id="B3" value="10"/>
            <count group_id="B4" value="29"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35.4" spread="5.8"/>
                    <measurement group_id="B2" value="34.3" spread="4.9"/>
                    <measurement group_id="B3" value="37.8" spread="4.6"/>
                    <measurement group_id="B4" value="35.9" spread="5.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="29"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.0" spread="7.5"/>
                    <measurement group_id="B2" value="32.0" spread="5.5"/>
                    <measurement group_id="B3" value="35.6" spread="9.4"/>
                    <measurement group_id="B4" value="33.6" spread="7.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Insurance Payer</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Private</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Public</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Parity</title>
          <units>prior deliveries</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1" lower_limit="0" upper_limit="1"/>
                    <measurement group_id="B2" value="1" lower_limit="1" upper_limit="1"/>
                    <measurement group_id="B3" value="1" lower_limit="0" upper_limit="1"/>
                    <measurement group_id="B4" value="1" lower_limit="0" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>GBS positivity</title>
          <description>As assessed by routine late third trimester screening (i.e. rectovaginal culture).</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Co-morbidity</title>
          <description>Includes maternal cardiac disease, diabetes on medications, hypertensive disease and cholestasis of pregnancy</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Post-intervention Aerobic Bacterial Colony Counts</title>
        <description>Vaginal cultures are collected after the vaginal preparation intervention. These undergo serial dilutions and are incubated on Tryptic Soy Agar for seven days. Bacteria colony counts were determined by blinded investigators on day 7.</description>
        <time_frame>From intervention to 7 days post</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Chlorhexidine-alcohol</title>
            <description>Subjects will receive vaginal preparation with chlorhexidine-alcohol.
Chlorhexidine-alcohol: Intervention is a 30-second vaginal preparation or topical wash with three chlorhexidine-alcohol 0.5% solution-soaked sponge sticks.</description>
          </group>
          <group group_id="O2">
            <title>Povidine-iodine</title>
            <description>Subjects will receive vaginal preparation with povidine-iodine.
Povidine-iodine: Intervention is a 30-second vaginal preparation or topical wash with three povidine-iodine 10% solution-soaked sponge sticks.</description>
          </group>
          <group group_id="O3">
            <title>Saline</title>
            <description>Subjects will receive vaginal preparation with sterile saline.
Sterile saline: Intervention is a 30-second vaginal preparation or topical wash with three sterile saline-soaked sponge sticks.</description>
          </group>
        </group_list>
        <measure>
          <title>Post-intervention Aerobic Bacterial Colony Counts</title>
          <description>Vaginal cultures are collected after the vaginal preparation intervention. These undergo serial dilutions and are incubated on Tryptic Soy Agar for seven days. Bacteria colony counts were determined by blinded investigators on day 7.</description>
          <units>Log (CFU/mL)</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.959" spread="0.624"/>
                    <measurement group_id="O2" value="0.945" spread="0.438"/>
                    <measurement group_id="O3" value="5.104" spread="0.299"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Post-intervention Anaerobic Bacterial Colony Counts</title>
        <description>Vaginal cultures are collected after the vaginal preparation intervention. These undergo serial dilutions and are incubated on Tryptic Soy Agar for seven days. Bacteria colony counts were determined by blinded investigators on day 7.</description>
        <time_frame>From intervention to 7 days post</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Chlorhexidine-alcohol</title>
            <description>Subjects will receive vaginal preparation with chlorhexidine-alcohol.
Chlorhexidine-alcohol: Intervention is a 30-second vaginal preparation or topical wash with three chlorhexidine-alcohol 0.5% solution-soaked sponge sticks.</description>
          </group>
          <group group_id="O2">
            <title>Povidine-iodine</title>
            <description>Subjects will receive vaginal preparation with povidine-iodine.
Povidine-iodine: Intervention is a 30-second vaginal preparation or topical wash with three povidine-iodine 10% solution-soaked sponge sticks.</description>
          </group>
          <group group_id="O3">
            <title>Saline</title>
            <description>Subjects will receive vaginal preparation with sterile saline.
Sterile saline: Intervention is a 30-second vaginal preparation or topical wash with three sterile saline-soaked sponge sticks.</description>
          </group>
        </group_list>
        <measure>
          <title>Post-intervention Anaerobic Bacterial Colony Counts</title>
          <description>Vaginal cultures are collected after the vaginal preparation intervention. These undergo serial dilutions and are incubated on Tryptic Soy Agar for seven days. Bacteria colony counts were determined by blinded investigators on day 7.</description>
          <units>Log (CFU/mL)</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.934" spread="0.514"/>
                    <measurement group_id="O2" value="2.637" spread="0.682"/>
                    <measurement group_id="O3" value="5.804" spread="0.212"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline Aerobic Bacterial Colony Counts</title>
        <description>Vaginal cultures are collected immediately prior to the vaginal preparation intervention. These undergo serial dilutions and are incubated on Tryptic Soy Agar for seven days. Bacteria colony counts were determined by blinded investigators on day 7.</description>
        <time_frame>From intervention to 7 days post</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Chlorhexidine-alcohol</title>
            <description>Subjects will receive vaginal preparation with chlorhexidine-alcohol.
Chlorhexidine-alcohol: Intervention is a 30-second vaginal preparation or topical wash with three chlorhexidine-alcohol 0.5% solution-soaked sponge sticks.</description>
          </group>
          <group group_id="O2">
            <title>Povidine-iodine</title>
            <description>Subjects will receive vaginal preparation with povidine-iodine.
Povidine-iodine: Intervention is a 30-second vaginal preparation or topical wash with three povidine-iodine 10% solution-soaked sponge sticks.</description>
          </group>
          <group group_id="O3">
            <title>Saline</title>
            <description>Subjects will receive vaginal preparation with sterile saline.
Sterile saline: Intervention is a 30-second vaginal preparation or topical wash with three sterile saline-soaked sponge sticks.</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Aerobic Bacterial Colony Counts</title>
          <description>Vaginal cultures are collected immediately prior to the vaginal preparation intervention. These undergo serial dilutions and are incubated on Tryptic Soy Agar for seven days. Bacteria colony counts were determined by blinded investigators on day 7.</description>
          <units>Log (CFU/mL)</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.942" spread="0.538"/>
                    <measurement group_id="O2" value="5.667" spread="0.437"/>
                    <measurement group_id="O3" value="6.480" spread="0.330"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline Anaerobic Bacterial Colony Counts</title>
        <description>Vaginal cultures are collected immediately prior to the vaginal preparation intervention. These undergo serial dilutions and are incubated on Tryptic Soy Agar for seven days. Bacteria colony counts were determined by blinded investigators on day 7.</description>
        <time_frame>From intervention to 7 days post</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Chlorhexidine-alcohol</title>
            <description>Subjects will receive vaginal preparation with chlorhexidine-alcohol.
Chlorhexidine-alcohol: Intervention is a 30-second vaginal preparation or topical wash with three chlorhexidine-alcohol 0.5% solution-soaked sponge sticks.</description>
          </group>
          <group group_id="O2">
            <title>Povidine-iodine</title>
            <description>Subjects will receive vaginal preparation with povidine-iodine.
Povidine-iodine: Intervention is a 30-second vaginal preparation or topical wash with three povidine-iodine 10% solution-soaked sponge sticks.</description>
          </group>
          <group group_id="O3">
            <title>Saline</title>
            <description>Subjects will receive vaginal preparation with sterile saline.
Sterile saline: Intervention is a 30-second vaginal preparation or topical wash with three sterile saline-soaked sponge sticks.</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Anaerobic Bacterial Colony Counts</title>
          <description>Vaginal cultures are collected immediately prior to the vaginal preparation intervention. These undergo serial dilutions and are incubated on Tryptic Soy Agar for seven days. Bacteria colony counts were determined by blinded investigators on day 7.</description>
          <units>Log (CFU/mL)</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.096" spread="0.240"/>
                    <measurement group_id="O2" value="6.745" spread="0.339"/>
                    <measurement group_id="O3" value="7.145" spread="0.316"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Participants Diagnosed With Postpartum Infections.</title>
        <description>Chart review to assess any maternal infections diagnosed during postpartum hospitalization or at the time of the postpartum visit.</description>
        <time_frame>Up to six weeks postpartum</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Chlorhexidine-alcohol</title>
            <description>Subjects will receive vaginal preparation with chlorhexidine-alcohol.
Chlorhexidine-alcohol: Intervention is a 30-second vaginal preparation or topical wash with three chlorhexidine-alcohol 0.5% solution-soaked sponge sticks.</description>
          </group>
          <group group_id="O2">
            <title>Povidine-iodine</title>
            <description>Subjects will receive vaginal preparation with povidine-iodine.
Povidine-iodine: Intervention is a 30-second vaginal preparation or topical wash with three povidine-iodine 10% solution-soaked sponge sticks.</description>
          </group>
          <group group_id="O3">
            <title>Saline</title>
            <description>Subjects will receive vaginal preparation with sterile saline.
Sterile saline: Intervention is a 30-second vaginal preparation or topical wash with three sterile saline-soaked sponge sticks.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Diagnosed With Postpartum Infections.</title>
          <description>Chart review to assess any maternal infections diagnosed during postpartum hospitalization or at the time of the postpartum visit.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From baseline to 6 weeks postpartum</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Chlorhexidine-alcohol</title>
          <description>Subjects will receive vaginal preparation with chlorhexidine-alcohol.
Chlorhexidine-alcohol: Intervention is a 30-second vaginal preparation or topical wash with three chlorhexidine-alcohol 0.5% solution-soaked sponge sticks.</description>
        </group>
        <group group_id="E2">
          <title>Povidine-iodine</title>
          <description>Subjects will receive vaginal preparation with povidine-iodine.
Povidine-iodine: Intervention is a 30-second vaginal preparation or topical wash with three povidine-iodine 10% solution-soaked sponge sticks.</description>
        </group>
        <group group_id="E3">
          <title>Saline</title>
          <description>Subjects will receive vaginal preparation with sterile saline.
Sterile saline: Intervention is a 30-second vaginal preparation or topical wash with three sterile saline-soaked sponge sticks.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="11"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Small sample size.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Cassandra R. Duffy, MD, MPH</name_or_title>
      <organization>Beth Israel Deaconess Medical Center</organization>
      <phone>617-667-2636</phone>
      <email>cduffy3@bidmc.harvard.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

